33 results on '"Tocco, A."'
Search Results
2. 7.2 EFFECT OF LURASIDONE ON MANIC SYMPTOMS AND TREATMENT-EMERGENT MANIA IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION
3. 7.5 LONG-TERM EFFICACY OF LURASIDONE IN PEDIATRIC BIPOLAR DEPRESSION: POST HOC ANALYSIS OF RESPONSE, REMISSION, AND RECOVERY
4. 7.5 LONG-TERM EFFICACY OF LURASIDONE IN PEDIATRIC BIPOLAR DEPRESSION: POST HOC ANALYSIS OF RESPONSE, REMISSION, AND RECOVERY
5. 7.2 EFFECT OF LURASIDONE ON MANIC SYMPTOMS AND TREATMENT-EMERGENT MANIA IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION
6. 4.51 LONG-TERM EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAÏVE VERSUS ANTIPSYCHOTIC-EXPOSED ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 2-YEAR, OPEN-LABEL STUDY
7. 5.28 LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: REMISSION AND RECOVERY DURING 2 YEARS OF OPEN-LABEL TREATMENT
8. 4.37 EFFICACY OF LURASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION: RESULTS FROM A 2-YEAR OPEN-LABEL EXTENSION STUDY
9. 5.10 EFFECT OF LURASIDONE ON COGNITIVE FUNCTION IN PEDIATRIC BIPOLAR DEPRESSION: RESULTS OF A 2-YEAR OPEN-LABEL EXTENSION STUDY
10. 6.16 Effect of Lurasidone on Neurocognitive Performance in Adolescents With Schizophrenia: Results of a Two-Year Open-Label Extension Study
11. 4.51 LONG-TERM EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAÏVE VERSUS ANTIPSYCHOTIC-EXPOSED ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 2-YEAR, OPEN-LABEL STUDY
12. 5.10 EFFECT OF LURASIDONE ON COGNITIVE FUNCTION IN PEDIATRIC BIPOLAR DEPRESSION: RESULTS OF A 2-YEAR OPEN-LABEL EXTENSION STUDY
13. 4.37 EFFICACY OF LURASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR DEPRESSION: RESULTS FROM A 2-YEAR OPEN-LABEL EXTENSION STUDY
14. 5.28 LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: REMISSION AND RECOVERY DURING 2 YEARS OF OPEN-LABEL TREATMENT
15. 2.5 Efficacy and Safety of Lurasidone in Adolescents With Schizophrenia: Results of a Two-Year Open-Label Extension Study
16. 6.16 Effect of Lurasidone on Neurocognitive Performance in Adolescents With Schizophrenia: Results of a Two-Year Open-Label Extension Study
17. 6.29 Efficacy of Lurasidone in Child and Adolescent Patients With Bipolar Depression and Anxiety: A Post-Hoc Analysis
18. 1.5 Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar Depression: Interim Analysis of a Two-Year Open-Label Extension Study
19. 5.50 Symptom Improvement Associated With Lurasidone Treatment of Children and Adolescents With Bipolar I Depression: Results of a Short-Term Placebo-Controlled Trial
20. 5.38 Effectiveness of Long-Term Treatment With Lurasidone in Children and Adolescents With Bipolar Depression: Week 28 Results of A Two-Year Open-Label Extension Study
21. 1.5 Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar Depression: Interim Analysis of a Two-Year Open-Label Extension Study
22. 2.5 Efficacy and Safety of Lurasidone in Adolescents With Schizophrenia: Results of a Two-Year Open-Label Extension Study
23. 6.29 Efficacy of Lurasidone in Child and Adolescent Patients With Bipolar Depression and Anxiety: A Post-Hoc Analysis
24. 1.50 Lurasidone in Children and Adolescents With Bipolar Depression Associated with Mixed (Subsyndromal Hypomanic) Features: Post Hoc Analysis of a Randomized Placebo-Controlled Trial
25. 5.38 Effectiveness of Long-Term Treatment With Lurasidone in Children and Adolescents With Bipolar Depression: Week 28 Results of A Two-Year Open-Label Extension Study
26. 5.50 Symptom Improvement Associated With Lurasidone Treatment of Children and Adolescents With Bipolar I Depression: Results of a Short-Term Placebo-Controlled Trial
27. 5.37 Effect of Lurasidone on Neurocognitive Performance in Children and Adolescents With Bipolar Depression: Results from a Placebo-Controlled Short-Term Study and an Open-Label Extension Study
28. 4.49 Efficacy and Safety of Lurasidone in Adolescents With Schizophrenia: Interim Analysis at Twelve Months of a 24-Month, Open-Label Extension Study
29. 1.34 Safety of Long-Term Treatment With Lurasidone in Children and Adolescents with Bipolar Depression: Week 28 Results of a Two-Year Open-Label Extension Study
30. 5.37 Effect of Lurasidone on Neurocognitive Performance in Children and Adolescents With Bipolar Depression: Results from a Placebo-Controlled Short-Term Study and an Open-Label Extension Study
31. 1.34 Safety of Long-Term Treatment With Lurasidone in Children and Adolescents with Bipolar Depression: Week 28 Results of a Two-Year Open-Label Extension Study
32. 1.50 Lurasidone in Children and Adolescents With Bipolar Depression Associated with Mixed (Subsyndromal Hypomanic) Features: Post Hoc Analysis of a Randomized Placebo-Controlled Trial
33. 4.49 Efficacy and Safety of Lurasidone in Adolescents With Schizophrenia: Interim Analysis at Twelve Months of a 24-Month, Open-Label Extension Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.